Monalizumab

Monalizumab Suppliers list

Company Name:	ShangHai Biochempartner Co.,Ltd
Tel:	17754423994 17754423994
Email:	2853530910@QQ.com
Products Intro:	Product Name:Monalizumab CAS:1228763-95-8 Purity:95% Package:100ug;500ug;1mg

Company Name:	Beijing Solarbio Science & Tecnology Co., Ltd.
Tel:	010-50973130 4009686088
Email:	3193328036@qq.com
Products Intro:	CAS:1228763-95-8

Company Name:	Wuhan Chemstan Biotechnology Co., Ltd.
Tel:	027-65317797 15926423062
Email:	422450190@qq.com
Products Intro:	Product Name:Monalizumab Purity:>95%;1mg/ml Package:200ug;500ug;1mg

Company Name:	AntibodySystem
Tel:	027-65279366 18162686757
Email:	biolab-reagents@atagenix.com
Products Intro:	Product Name:Research Grade Monalizumab(DHD71901) CAS:1228763-95-8 Purity:PAGE:>95% Package:100ug;1mg

Company Name:	Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel:	13720134139 13720134139
Email:	orders@jknbiochem.com
Products Intro:	Product Name:Monalizumab CAS:1228763-95-8 Purity:95% Package:100ug:500ug:1mg

Monalizumab Basic information

Product Name:	Monalizumab
Synonyms:	Monalizumab;Research Grade Monalizumab(DHD71901)
CAS:	1228763-95-8
MF:
MW:	0
EINECS:
Product Categories:
Mol File:	Mol File

Monalizumab Chemical Properties

storage temp.	Store at -20°C
Water Solubility	Soluble in water

Safety Information

MSDS Information

Monalizumab Usage And Synthesis

Uses	Monalizumab (IPH2201) is a potentially first-in-class immune checkpoint inhibitor targeting NKG2A receptors expressed on tumor infiltrating cytotoxic CD8+ T cells and NK cells.
Mechanism of action	Monalizumab is a blocking antibody that prevents the inhibition of CD8+ T cells and NK cell by tumor cells expressing HLA-E. By acting simultaneously on innate and adaptive immunity, monalizumab may re-establish a broad anti-tumor response.

Monalizumab Preparation Products And Raw materials

Tag:Monalizumab(1228763-95-8) Related Product Information

Durvalumab Denosumab Evolocumab Enfortumab Vedotin Avelumab Alirocumab Nivolumab Tislelizumab Toripalimab Lambrolizumab

Login